Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.

Eron JJ, Young B, Cooper DA, Youle M, Dejesus E, Andrade-Villanueva J, Workman C, Zajdenverg R, Fätkenheuer G, Berger DS, Kumar PN, Rodgers AJ, Shaughnessy MA, Walker ML, Barnard RJ, Miller MD, Dinubile MJ, Nguyen BY, Leavitt R, Xu X, Sklar P; SWITCHMRK 1 and 2 investigators.

Lancet. 2010 Jan 30;375(9712):396-407. doi: 10.1016/S0140-6736(09)62041-9. Epub 2010 Jan 12.

PMID:
20074791
2.
3.

Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis.

Grammer LC, Shaughnessy MA, Harris KE, Goolsby CL.

Ann Allergy Asthma Immunol. 2000 Nov;85(5):368-71.

PMID:
11101177
4.

Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate.

Geha RS, Beiser A, Ren C, Patterson R, Greenberger PA, Grammer LC, Ditto AM, Harris KE, Shaughnessy MA, Yarnold PR, Corren J, Saxon A.

J Allergy Clin Immunol. 2000 Nov;106(5):973-80.

PMID:
11080723
5.

Human leucocyte antigens (HLA) and trimellitic anhydride (TMA) immunological lung disease.

Grammer LC, Zeiss CR, Yarnold PR, Shaughnessy MA.

Respir Med. 2000 Oct;94(10):964-70.

6.

Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study.

Geha RS, Beiser A, Ren C, Patterson R, Greenberger PA, Grammer LC, Ditto AM, Harris KE, Shaughnessy MA, Yarnold PR, Corren J, Saxon A.

J Nutr. 2000 Apr;130(4S Suppl):1058S-62S. doi: 10.1093/jn/130.4.1058S. Review.

PMID:
10736382
7.

A clinical and immunologic study to assess risk of TMA-induced lung disease as related to exposure.

Grammer LC, Shaughnessy MA, Kenamore BD, Yarnold PR.

J Occup Environ Med. 1999 Dec;41(12):1048-51.

PMID:
10609223
8.
9.

Potential effect of the administration of substance P and allergen therapy on immunoglobulin E-mediated allergic reactions in human subjects.

Patterson R, Harris KE, Grammer LC, Greenberger PA, Ditto AM, Shaughnessy MA.

J Lab Clin Med. 1999 Feb;133(2):189-99.

PMID:
9989771
10.

Immunologic aspects of isocyanate asthma: IL-1 beta, IL-3, IL-4, sIL2R, and sICAM-1.

Grammer LC, Shaughnessy MA, Kabalin CS, Yarnold PR, Malo JL, Cartier A.

Allergy Asthma Proc. 1998 Sep-Oct;19(5):301-5.

PMID:
9801744
11.

A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity.

Pinto LH, Dieckmann GR, Gandhi CS, Papworth CG, Braman J, Shaughnessy MA, Lear JD, Lamb RA, DeGrado WF.

Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11301-6.

12.

Review of trimellitic anhydride (TMA) induced respiratory response.

Grammer LC, Shaughnessy MA, Zeiss CR, Greenberger PA, Patterson R.

Allergy Asthma Proc. 1997 Jul-Aug;18(4):235-7. Review.

PMID:
9270885
13.

Study of employees with anhydride-induced respiratory disease after removal from exposure.

Grammer LC, Shaughnessy MA.

J Occup Environ Med. 1996 Aug;38(8):771-4.

PMID:
8863202
14.

Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.

Tu Q, Pinto LH, Luo G, Shaughnessy MA, Mullaney D, Kurtz S, Krystal M, Lamb RA.

J Virol. 1996 Jul;70(7):4246-52.

15.
16.

Total serum IgE in trimellitic anhydride-induced asthma.

Backman KS, Shaughnessy MA, Harris KE, Grammer LC.

J Occup Environ Med. 1996 Apr;38(4):347-51.

PMID:
8925317
17.

Study of employees with anhydride-induced respiratory disease after removal from exposure.

Grammer LC, Shaughnessy MA, Hogan MB, Lowenthal M, Yarnold PR, Watkins DM, Berggruen SM.

J Occup Environ Med. 1995 Jul;37(7):820-5.

PMID:
7552466
18.

Value of antibody level in diagnosing anhydride-induced immunologic respiratory disease.

Grammer LC, Shaughnessy MA, Hogan MB, Berggruen SM, Watkins DM, Yarnold PR.

J Lab Clin Med. 1995 May;125(5):650-3.

PMID:
7738429
19.

The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions.

Paterson RG, Leser GP, Shaughnessy MA, Lamb RA.

Virology. 1995 Apr 1;208(1):121-31.

20.

Analysis of the posttranslational modifications of the influenza virus M2 protein.

Holsinger LJ, Shaughnessy MA, Micko A, Pinto LH, Lamb RA.

J Virol. 1995 Feb;69(2):1219-25.

21.
22.

Evolution of patient care, education, and research in asthma by one academic team of investigators over 35 years: the Northwestern University Medical School Division of Allergy-Immunology experience (Part Two).

Patterson R, De Swarte RD, Grammer LC, Greenberger PA, Harris KE, McGrath K, Pruzansky JJ, Shaughnessy MA, Zeiss CR.

Allergy Proc. 1994 Jul-Aug;15(4):223-32. Review.

PMID:
7528703
23.

Immunologic cross-reactivity of acid anhydrides with immunoglobulin E against trimellityl-human serum albumin.

Lowenthal M, Shaughnessy MA, Harris KE, Grammer LC.

J Lab Clin Med. 1994 Jun;123(6):869-73.

PMID:
8201265
24.

Risk factors for immunologically mediated respiratory disease from hexahydrophthalic anhydride.

Grammer LC, Shaughnessy MA, Lowenthal M, Yarnold PR.

J Occup Med. 1994 Jun;36(6):642-6.

PMID:
8071727
25.

Evolution of patient care, education, and research in asthma by one academic team of investigators over 35 years. The Northwestern University Medical School Division of Allergy-Immunology Experience: Part One.

Patterson R, DeSwarte RD, Grammer LC, Greenberger PA, Harris KE, McGrath K, Pruzansky JJ, Shaughnessy MA, Zeiss CR.

Allergy Proc. 1994 May-Jun;15(3):169-78.

PMID:
7926718
26.

Respiratory and systemic reaction following exposure to heated electrostatic polyester paint.

Cartier A, Vandenplas O, Grammer LC, Shaughnessy MA, Malo JL.

Eur Respir J. 1994 Mar;7(3):608-11.

27.

Hemorrhagic rhinitis. An immunologic disease due to hexahydrophthalic anhydride.

Grammer LC, Shaughnessy MA, Lowenthal M.

Chest. 1993 Dec;104(6):1792-4.

PMID:
8252966
28.

Idiopathic anaphylaxis (IA): suggested theories relative to the pathogenesis and response to therapy.

Patterson R, Greenberger PA, Grammer LC, Zeiss CR, Harris KE, Shaughnessy MA.

Allergy Proc. 1993 Sep-Oct;14(5):365-7. No abstract available.

PMID:
8288120
29.

A clinical and immunologic study of workers with trimellitic-anhydride-induced immunologic lung disease after transfer to low exposure jobs.

Grammer LC, Shaughnessy MA, Henderson J, Zeiss CR, Kavich DE, Collins MJ, Pecis KM, Kenamore BD.

Am Rev Respir Dis. 1993 Jul;148(1):54-7.

PMID:
8317814
30.

ELISA screening tests for specific IgE and IgG antibody in employees exposed to trimellitic anhydride (TMA).

Grammer L, Shaughnessy MA, Watkins D, Henderson J, Zeiss CR.

Allergy Proc. 1993 Jul-Aug;14(4):269-71.

PMID:
8224833
31.

Immunologic specificity of IgG against trimellityl-human serum albumin in serum samples of workers exposed to trimellitic anhydride.

Gerhardsson L, Grammer LC, Shaughnessy MA, Patterson R.

J Lab Clin Med. 1993 Jun;121(6):792-6.

PMID:
8505590
32.

Polymerization and fractionation of house dust mite allergen.

Grammer LC, Shaughnessy MA, Holmquist LS, Pruzansky JJ, Patterson R.

Allergy Proc. 1993 May-Jun;14(3):195-9.

PMID:
8354481
33.

Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma.

Vandenplas O, Cartier A, Lesage J, Cloutier Y, Perreault G, Grammer LC, Shaughnessy MA, Malo JL.

J Allergy Clin Immunol. 1993 Apr;91(4):850-61.

PMID:
8473673
34.

Allergen immunotherapy: definition, indication, and reactions.

Grammer L, Shaughnessy MA.

Allergy Proc. 1993 Mar-Apr;14(2):108-9. No abstract available.

PMID:
8514161
35.

An overview of allergens.

Sonenthal KR, Shaughnessy MA.

Allergy Proc. 1993 Mar-Apr;14(2):106-7. No abstract available.

PMID:
8514160
36.
37.

Hypersensitivity pneumonitis-like reaction among workers exposed to diphenylmethane [correction to piphenylmethane] diisocyanate (MDI).

Vandenplas O, Malo JL, Dugas M, Cartier A, Desjardins A, Lévesque J, Shaughnessy MA, Grammer LC.

Am Rev Respir Dis. 1993 Feb;147(2):338-46.

PMID:
8430956
38.

IgG subclass antibody against trimellitic anhydride in workers with and without immunologic lung diseases.

Gerhardsson L, Grammer LC, Shaughnessy MA, Patterson R.

J Occup Med. 1992 Oct;34(10):989-92.

PMID:
1403199
39.

Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.

Horvath CM, Paterson RG, Shaughnessy MA, Wood R, Lamb RA.

J Virol. 1992 Jul;66(7):4564-9.

40.

Environmental monitoring: correlating air measurements of substances with immune response.

Grammer LC, Shaughnessy MA.

Occup Med. 1992 Apr-Jun;7(2):261-70. Review.

PMID:
1615362
41.

Anaphylaxis during intrauterine insemination secondary to bovine serum albumin.

Sonenthal KR, McKnight T, Shaughnessy MA, Grammer LC, Jeyendran RS.

Fertil Steril. 1991 Dec;56(6):1188-91.

PMID:
1743343
42.

Antibodies to toluene diisocyanate in patients with and without dialysis anaphylaxis.

Grammer LC, Harris KE, Shaughnessy MA, Dolovich J, Patterson R, Evans S.

Artif Organs. 1991 Feb;15(1):2-4.

PMID:
1847799
43.

Use of immunologic technology in the diagnosis of environmental and occupational immunologic lung disease.

Patterson R, Grammer LC, Zeiss CR, Harris KE, Shaughnessy MA.

Chest. 1990 Nov;98(5 Suppl):206S-208S. Review. No abstract available.

PMID:
2226011
44.
45.

Clinical and immunologic evaluation of 37 workers exposed to gaseous formaldehyde.

Grammer LC, Harris KE, Shaughnessy MA, Sparks P, Ayars GH, Altman LC, Patterson R.

J Allergy Clin Immunol. 1990 Aug;86(2):177-81.

PMID:
2384647
46.

Human IgE, IgG and IgA antibody responses to T101, a murine monoclonal antibody against human lymphocytes: implications for pathogenesis, risk and avoidance of adverse immunologic reactions.

Dykewicz MS, Cranberg JA, Patterson R, Rosen ST, Shaughnessy MA, Zimmer AM.

Int Arch Allergy Appl Immunol. 1990;92(2):131-7.

PMID:
2242927
47.

IgG antibody against formaldehyde human serum proteins: a comparison with other IgG antibodies against inhalant proteins and reactive chemicals.

Patterson R, Dykewicz MS, Evans R 3rd, Grammer LC, Greenberger PA, Harris KE, Lawrence ID, Pruzansky JJ, Roberts M, Shaughnessy MA, et al.

J Allergy Clin Immunol. 1989 Sep;84(3):359-66.

PMID:
2778242
48.

Baker's asthma: report of an unusual case.

Walker CL, Grammer LC, Shaughnessy MA, Patterson R.

J Occup Med. 1989 May;31(5):439-42.

PMID:
2715851
49.

Diphenylmethane diisocyanate hypersensitivity pneumonitis: a serologic evaluation.

Walker CL, Grammer LC, Shaughnessy MA, Duffy M, Stoltzfus VD, Patterson R.

J Occup Med. 1989 Apr;31(4):315-9.

PMID:
2715837
50.

Safety and immunogenicity of immunotherapy with accelerated dosage schedules of polymerized grass and ragweed in patients with dual inhalant sensitivity.

Grammer LC, Shaughnessy MA, Shaughnessy JJ, Patterson R.

J Allergy Clin Immunol. 1989 Apr;83(4):750-6.

PMID:
2708735

Supplemental Content

Loading ...
Support Center